# Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

> **NCT03486262** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 100 (estimated)

## Conditions studied

- Lung Cancer and Idiopathic Pulmonary Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03486262
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-01
- **Primary completion:** 2020-02
- **Final completion:** 2020-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03486262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03486262, "Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03486262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*